Shamburg News · 8-K filed Oct 1, 2026, 4:30 PM EDT

Fortress Biotech Repays Remaining $15.0 Million Under Oaktree Credit Facility

FBIO · Fortress Biotech, Inc.

  • Financing
  • Material agreement
  • Other event
  • Materiality: medium

Fortress Biotech, Inc. repaid in full the remaining $15.0 million in principal outstanding under its senior secured Oaktree credit agreement on September 30, 2026. The repayment included approximately $435,000 in accrued interest, a $150,000 prepayment fee and other closing costs. Upon repayment, the indebtedness was satisfied, liens on the company's property were released, and the Oaktree Agreement terminated.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001104659-26-112845.

Written from the filing by Shamburg Markets. Figures are as reported by the company.